Cap Wealth Advisors, LLC Veracyte, Inc. Transaction History

Cap Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$19.49 - $28.11 $178,742 - $257,796	-9,171 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$16.13 - $30.17 $16,936 - $31,678	1,050 Added 12.93%	9,171 $223,000
Q1 2020 May 08, 2020	SELL	$16.13 - $30.17 $1,742 - $3,258	-108 Reduced 1.31%	8,121 $197,000
Q4 2019 Feb 06, 2020	BUY	$20.78 - $29.99 $170,998 - $246,787	8,229 New	8,229 $230,000
Q3 2019 Oct 29, 2019	SELL	$23.87 - $30.93 $193,848 - $251,182	-8,121 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$22.1 - $28.56 $179,474 - $231,935	8,121 New	8,121 $232,000

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Cap Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Cap Wealth Advisors, LLC with notifications on news.